A Multi-Center Study to Evaluate Acute Safety and Clinical Performance of Paladin® Carotid Post-Dilation Balloon System With Integrated Embolic Protection
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Prof. Horst Sievert, MD
CardioVascular Center, Sankt Katharinen Hospital
Principal Investigator - Prof. Thomas Zeller, MD
Universitäts Herzzentrum Freiburg Bad-Krozingen
Principal Investigator
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
5 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Universitäts-Herzzentrum Bad Krozingen
Bad Krozingen, Germany
- Sankt Gertrauden Krankenhaus
Berlin, Germany
- Cardiovascular Centre Frankfurt
Frankfurt, Germany
- Medizinisches Versorgungszentrum Prof. Mathey, Prof. Schofer Gmbh
Hamburg, Germany
- Universitätsklinikum Leipzig
Leipzig, Germany
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 31 Aug 2015
- Primary completion
- 30 Sept 2016
- Completion
- 31 Oct 2016
- Last update posted
- 21 Nov 2022
- Registered enrollment
- 106
- Registry id
- NCT02501148
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.